98. Eosinophilic gastrointestinal disease Clinical trials / Disease details
Clinical trials : 171 / Drugs : 184 - (DrugBank : 47) / Drug target genes : 42 - Drug target pathways : 141
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04248712 (ClinicalTrials.gov) | July 10, 2020 | 28/1/2020 | Antihistamines in Eosinophilic Esophagitis | A Phase II, Randomized, Placebo-controlled Study Evaluating the Efficacy of Antihistamines in the Treatment of Eosinophilic Esophagitis (the ATEE Study) | Eosinophilic Esophagitis | Drug: Famotidine;Drug: Loratadine;Drug: Placebo | Mayo Clinic | NULL | Recruiting | 18 Years | N/A | All | 50 | Phase 2 | United States |